Moderna has revealed more COVID-19 vaccine production details, outlining the ramp-up of its drug as we head into early 2021. The vaccine candidate, which the FDA will hold a public Vaccines and Related Biological Products Advisory Committee meeting on later this month, is currently being considered for emergency use authorization as the pandemic toll continues to rise. Moderna’s drug, mRNA-1273, …
Moderna has revealed more COVID-19 vaccine production details, outlining the ramp-up of its drug as we head into early 2021. The vaccine candidate, which the FDA will hold a public Vaccines and Related Biological Products Advisory Committee meeting on later this month, is currently being considered for emergency use authorization as the pandemic toll continues to rise. Moderna’s drug, mRNA-1273, …
Share this Article
Recommended